ClinicalTrials.Veeva

Menu

Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Allogene MSCs Transplantation
Peripheral Vein
Chronic Liver Diseases Patients

Study type

Observational

Funder types

Other

Identifiers

NCT01256125
SunYat-sen U 11-5-1

Details and patient eligibility

About

Allogene MSCs transplantation will be performed in patients with chronic liver diseases through peripheral vein and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.

Enrollment

60 estimated patients

Sex

All

Ages

15 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune liver disease.
  2. age: 15-65 years old.

Exclusion criteria

  1. pregnant women and women in lactation.
  2. other systems and organs disfunction
  3. space-occupying lesion were found in liver.
  4. concurrent infection with HIV and other immunodeficiency diseases.
  5. DIC and active bleeding were confirmed.

Trial design

60 participants in 2 patient groups

Allogene MSCs transplantation
Description:
Allogene MSCs transplantation were performed in patients with chronic liver diseases through peripheral vein plus the same medical treatments.
control
Description:
only medical treatments were performed in patients with chronic liver diseases.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems